Mora M, Angelini C, Bignami F, Bodin AM, Crimi M, Di Donato JH, Felice A, Jaeger C, Karcag V,LeCam Y, Lynn S, Meznaric M, Moggio M, Monaco L, Politano L, Posada de la Paz M, Saker S, Schneiderat P, Ensini M,Garavaglia B, Gurwitz D, Johnson D, Muntoni F, Puymirat J, Reza M, Voit T, Baldo C, Bricarelli FD, Goldwurm S, Merla G, Pegoraro E, Renieri A, Zatloukal K, Filocamo M, Lochmüller H
European Journal of Human Genetics, 23, 1116–1123, December 2014
The EuroBioBank (EBB) network (www.eurobiobank.org) is the first operating network of biobanks in Europe to provide human DNA, cell and tissue samples as a service to the scientific community conducting research on Rare Diseases (RDs). The EBB was established in 2001 to facilitate access to RD biospecimens and associated data; it obtained funding from the European Commission in 2002 (5th framework programme) and started operation in 2003. The set-up phase, during the EC funding period 2003-2006, established the basis for running the network; the following consolidation phase has seen the growth of the network through the joining of new partners, better network cohesion, improved coordination of activities, and the development of a quality control system. During this phase the network participated in the EC-funded TREAT-NMD programme and was involved in planning of the European Biobanking and Biomolecular Resources Research Infrastructure. Recently, EBB became a partner of RD-Connect, an FP7 EU program aimed at linking RD biobanks, registries and bioinformatics data. Within RD-Connect, EBB contributes expertise, promotes high professional standards and best practices in RD biobanking, is implementing integration with RD patient registries and “omics” data, thus challenging the fragmentation of international cooperation on the field.